Tirzepatide activates both GLP-1 and GIP receptor pathways
Gothelf, Y., Abramov, N., Harel, A
The ongoing evaluation of Monlunabant aims to optimize its benefits while minimizing adverse effects, ensuring it remains a viable choice for long-term weight management
Their observed influence on inflammatory pathways, collagen synthesis, and vascular support highlights promising directions for continued exploration
Diabetes Obes Metab 23:21772182 Frazer M, Swift C, Gronroos NN, Sargent A, Leszko M, Buysman E, Alvarez S, Dunn TJ, Noone J, Guevarra M (2023) Real-world hemoglobin A1c changes, prescribing provider types, and medication dose among patients with type 2 diabetes mellitus initiating treatment with oral semaglutide